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Background: This paper describes fidelity monitoring (treatment differentiation, training, delivery, receipt and enactment)
across the seven National Institutes of Health-supported Consortium of Hospitals Advancing Research on Tobacco
(CHART) studies. The objectives of the study were to describe approaches to monitoring fidelity including treatment
differentiation (lack of crossover), provider training, provider delivery of treatment, patient receipt of treatment, and
patient enactment (behavior) and provide examples of application of these principles.
Methods: Conducted between 2010 and 2014 and collectively enrolling over 9500 inpatient cigarette smokers, the
CHART studies tested different smoking cessation interventions (counseling, medications, and follow-up calls) shown to
be efficacious in Cochrane Collaborative Reviews. The CHART studies compared their unique treatment arm(s) to usual
care, used common core measures at baseline and 6-month follow-up, but varied in their approaches to monitoring the
fidelity with which the interventions were implemented.
Results: Treatment differentiation strategies included the use of a quasi-experimental design and monitoring of both the
intervention and control group. Almost all of the studies had extensive training for personnel and used a checklist to
monitor the intervention components, but the items on these checklists varied widely and were based on unique aspects
of the interventions, US Public Health Service and Joint Commission smoking cessation standards, or counselor rapport.
Delivery of medications ranged from 31 to 100 % across the studies, with higher levels from studies that gave away free
medications and lower levels from studies that sought to obtain prescriptions for the patient in real world systems.
Treatment delivery was highest among those studies that used automated (interactive voice response and website)
systems, but this did not automatically translate into treatment receipt and enactment. Some studies measured treatment
enactment in two ways (e.g., counselor or automated system report versus patient report) showing concurrence or
discordance between the two measures.
Conclusion: While fidelity monitoring can be challenging especially in dissemination trials, the seven CHART studies used
a variety of methods to enhance fidelity with consideration for feasibility and sustainability.
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Trial registration:
 Dissemination of Tobacco Tactics for hospitalized smokers. Clinical Trials Registration No. NCT01309217.
 Smoking cessation in hospitalized smokers. Clinical Trials Registration No. NCT01289275.
 Using “warm handoffs” to link hospitalized smokers with tobacco treatment after discharge: study protocol of a
randomized controlled trial. Clinical Trials Registration No. NCT01305928.
 Web-based smoking cessation intervention that transitions from inpatient to outpatient. Clinical Trials Registration
No. NCT01277250.
 Effectiveness of smoking-cessation interventions for urban hospital patients. Clinical Trials Registration No.
NCT01363245.
 Comparative effectiveness of post-discharge interventions for hospitalized smokers. Clinical Trials Registration No.
NCT01177176.
 Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized
smokers in two large hospitals. Clinical Trials Registration No. NCT01236079.
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Treatment fidelity is the extent to which an intervention
is implemented as designed [1]. The rationale for moni-
toring fidelity is to address the methodological strategies
used to monitor and enhance reliability and validity of
the intervention [2]. Moreover, fidelity speaks to the de-
gree of integrity of an intervention. Ensuring treatment
fidelity gives researchers more confidence in their results
[2] and increases credibility [3], particularly in trials con-
ducted in community settings where there are diverse
settings, therapists, and patients [4, 5].
Lack of fidelity refers to any gap between the inter-
vention as it was planned and the intervention as it
was actually implemented [6]. If a treatment was not
given completely as designed and statistical effects of
the treatment are non-significant, then the treatment
may be discarded prematurely. Indeed, higher treat-
ment fidelity has been linked to improved outcomes
[6]. If significant effects were found, but fidelity was
not monitored, then it is unclear whether the differ-
ence was due to the intervention itself or to something
else [2, 7]. Fidelity measures can be monitored and in-
cluded in statistical analysis (e.g., the number of times an
individual subject was reached on the phone to assess the
implementation of a phone intervention) and therefore in-
crease knowledge about how the components of an inter-
vention influence the outcome. Finally, the assessment of
treatment fidelity serves to identify barriers to imple-
mentation that need to be addressed and modified in
order to ensure that the intervention has a greater
chance of sustainability [8].
The five main components of fidelity monitoring are well
established and include study design, training, delivery,
receipt, and enactment [2, 9, 10]. Study design monitoringincludes consideration on whether or not the inter-
vention is sufficiently differentiated from the control
group (avoidance of cross-contamination). Standard-
ized trainings of providers/interventionists support
standardized treatment delivery. In addition, monitor-
ing and maintaining provider skills over time is a ne-
cessity. Treatment delivery measures whether or not
the treatment was delivered as intended. Treatment
receipt measures whether or not the participant un-
derstands the intervention and indicates confidence
and ability to apply the skills learned in the interven-
tion. Treatment enactment measures whether or not
the participant participated in the intervention.
While many studies have been published on the im-
portance of fidelity monitoring and some have pub-
lished results from their own studies, no papers that
we know of have published approaches to fidelity
monitoring across several smoking cessation studies.
Hence, this paper will describe the methods of fidelity
monitoring and provide fidelity data across seven
studies that were funded by the National Institutes of
Health (NIH) to disseminate unique smoking cessa-
tion interventions to hospitalized smokers. Since fidel-
ity influences both the degree to which changes can be
attributed to the intervention (internal validity), and
the ability to replicate and disseminate the interven-
tion (external validity) [11], the assessment of treat-
ment fidelity across the seven studies may be useful to
researchers conducting smoking cessation and other
behavioral intervention trials [7, 9–13].
Methods
Collectively called the Consortium of Hospitals Ad-
vancing Research on Tobacco (CHART), these studies
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9500 inpatient cigarette smokers to test the effective-
ness of these unique smoking cessation interventions.
The protocols of these seven studies have been pub-
lished [14–21] and outcome papers will follow. All of
the CHART studies implemented the components of
smoking cessation interventions shown to be efficacious
in Cochrane Collaborative Reviews [22] including medica-
tion and behavioral counseling and follow-up calls. Al-
though usual care varied across the seven studies, all of
the CHART studies compared their unique treatment
arm(s) to usual care and used common core measures
at the baseline and 6-month follow-up. However, each
study was unique in how fidelity was monitored. A
brief overview of each study design follows.
University of Michigan Medical Center (UMMC)
The Tobacco Tactics study used a quasi-experimental
design in five Michigan Trinity Health System Hospitals.
Nurses in three experimental hospitals were taught to
conduct the in-hospital, face-to-face Tobacco Tactics
intervention in a 1-h educational session using the
Tobacco Tactics toolkit. Nurses in the other two hospitals
continued usual care (brief advice and brochure). Nurses
and inpatient smokers (N = 1528) regardless of motivation
to quit in both the experimental and control sites
were surveyed pre- and post-implementation of the
intervention [15].
University of California, San Diego (UCSD)
In this 2 by 2 factorial randomized controlled trial
(RCT), 1270 inpatient smokers motivated to quit from
three healthcare systems (a total of 5 hospitals) in San
Diego and Davis, CA were randomized to one of four
conditions: 1) usual care; 2) nicotine patches provided
at the time of discharge; 3) telephone counseling after
discharge and; 4) nicotine patches at discharge plus
telephone counseling after discharge. Six standard
counseling sessions were proactively provided by the
state quitline post discharge. Subjects in the patch condi-
tions received 8 weeks of nicotine patches at the time of
discharge [16].
University of Kansas (KU)
This RCT compared warm-handoff versus fax referral
(usual care) for linking hospitalized smokers motivated
to quit to state quitline services (N = 1054) from two
large hospitals. Counselors provided brief cessation ad-
vice to all patients and provided them with a standard
smoking cessation booklet. In the warm hand-off inter-
vention condition, patients received an abbreviated
bedside intervention and the counselor called the quit
line and transferred the call to the patient’s bedside
hospital phone or mobile phone before leaving. In thecontrol condition, fax-referral patients received the
usual care cessation counseling and were fax referred
to the quitline. Outcome data collected from the state
quit line provider, Alere Well Being (AWB), included
enrollment and number of calls completed out of a
total of 5 intervention calls [21].
New York University (NYU)
This RCT compared two methods of smoking cessation de-
livered to all inpatient smokers regardless of motivation to
quit discharged from two urban public hospitals in New
York City (Bellevue and the Manhattan VA): 1) seven ses-
sions of proactive telephone counseling delivered by study
staff; or 2) referral to the New York State Quitline via fax
or online referral (n = 805). Counselors in the intervention
arm assisted patients (n = 805) in obtaining four weeks of
NRT patch or gum after discharge. Counselors in the
Quitline arm assisted patients (n = 814) in obtaining NRT
following usual Quitline protocols (N = 1619). For most
participants this was two weeks of NRT patch or gum [17].
University of Alabama at Birmingham (UAB)
This RCT randomized all smokers regardless of mo-
tivation to quit in a large university hospital who had
an email address and access to the internet to: 1)
usual care; or 2) the web-based Decide2Quit interven-
tion. The intervention included a visit by a counselor
who introduced them to the web-site, assisted them
with registering to the site, and provided a booklet
that gave an overview of the web-site, including infor-
mation to help them log into the site on their own
(N = 1488). If the participant was discharged prior to
the bedside registration, a booklet was sent to their home
address and a counselor walked them through website
registration and orientation over the phone. Questions
completed during the intervention registration informed
tailored email messages automatically sent on a scheduled
basis. The website allowed participants to send messages
to a counselor and receive responses. Participants were
called between 10 and 30 days post hospitalization to en-
courage use of the web-site [18].
Kaiser Permanente Center for Health Research (KPCHR)
The Inpatient Technology-Supported Assisted Refer-
ral (ITSAR) study was a RCT recruiting smokers
motivated to quit in three large hospitals serving the
Portland OR metropolitan area that compared: 1)
adding an assisted referral (AR) to available out-
patient quit services and medications following dis-
charge and four post-discharge Interactive Voice
Response (IVR) telephone follow-up calls (AR + IVR);
and 2) usual care bedside cessation counseling, medi-
cation, and information about available quit services.
IVR calls captured smoking status, cessation program
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supportive messages. Nine hundred participants were
recruited (599 to AR + IVR and 301 to usual care)
using a 2:1 recruitment strategy [19].
Massachusetts General Hospital (MGH)
The RCT Hospital-Initiated Assistance for Nicotine De-
pendence 2 (Helping HAND 2) is a multisite iteration of
Helping HAND 1 [23] and is enrolling 1350 adult
smokers motivated to quit admitted to 3 acute care hos-
pitals in Massachusetts and Pennsylvania. Data are in-
cluded on 529 participants who were enrolled at the
time of this writing. All subjects received brief in-
hospital smoking intervention and were randomly
assigned at discharge to either usual care (referral to the
Massachusetts or Pennsylvania state quitline) or ex-
tended care intervention, which consisted of a 3-month
program with 2 components: 1) free medication (30-day
supply of FDA-approved medication including nicotine
replacement, bupropion, or varenicline) given at hos-
pital discharge and refillable free for a total of 90 days
to facilitate medication use and adherence; and 2) Tel
ASK (participating IVR company) triage to telephone
counseling from a national quitline provider, Alere
Well Being (AWI) [20].
Results
Table 1 summarizes how each of the five components of fi-
delity were addressed and monitored by each of the seven
CHART studies. Selected results of the fidelity data from
each site follows. Figure 1 and Tables 2, 3, 4, 5, 6 and 7
show examples of the components of fidelity monitoring
from each site with corresponding data.
University of Michigan Medical Center (UMMC)
Figure 1 shows the results for treatment delivery
assessed using the nurse interviews conducted with 11 %
(n = 140) of nurses in the intervention sites. Nurses re-
ported high delivery rates on most items, except for
showing the DVD. Qualitative comments from the
nurses indicated that the overhead television system was
often not working or when it was working, it was cum-
bersome to use. One nurse who did not attend the train-
ing reported delivering the intervention as she learned it
from the other nurses.
University of California, San Diego (UCSD)
A chart audit showed that treatment differentiation
was high in that no patients in the control or counsel-
ing only group were given nicotine patches at dis-
charge. Examination of the quitline data revealed that
10 subjects (<1 %) in the control or patch only group
proactively called the quitline after hospital discharge
and received counseling. Table 2 shows an example ofmonitoring the treatment delivery comparing the rates
for those in the patch only condition to those in the
counseling plus patch condition. Overall 55.1 % re-
ceived their patches upon discharge, 34.5 % were
mailed patches after discharge, 1.7 % refused, and
8.6 % were unknown. There was greater difficulty deliv-
ering patches to subjects in the combined counseling plus
patch condition than the patches only condition (58.0 %
versus 67.5 %; p < .05).
University of Kansas (KU)
Table 3 shows fidelity data for treatment delivery
assessed using 108 direct observations of counselors in
both the intervention (n = 57) and control (n = 51) arms.
The mean fidelity was 94 % for both the treatment and
control arms. In terms of treatment enactment, 99.6 %
of participants assigned to warm hand-off intervention
enrolled, while only 59.6 % of participants assigned to
fax referral control arm enrolled (p < .001). The rates of
completed calls were as follows: 31 % did not complete
any calls, 25 % completed 1 call, 16 % completed 2 calls,
12 % completed 3 calls, 9 % completed 4 calls, and 7 %
completed 5 calls.
New York University (NYU)
Table 4 shows treatment delivery for smoking cessa-
tion medications; 32 % of intervention participants
were interested in receiving NRT, 31 % were delivered
NRT, and 8 % received a NRT prescription on hos-
pital discharge. In terms of treatment enactment,
52 % of participants randomized to the intervention
arm (n = 805) completed at least one counseling call
and only 14 % received all seven counseling calls. Par-
ticipants completed an average of two counseling calls
(the average was four calls among participants who
began counseling). The average length of the first call
was 22 min and follow-up calls averaged 13 min.
Eighty-one participants set a quit date with their
counselor (10 % of all intervention participants; 20 %
of those who began counseling) and 218 participants
reported using NRT to a counselor (27 % of all inter-
vention participants; 52 % of those who began coun-
seling). Similarly, 2-month follow-up surveys showed
that 48 % of intervention participants (384/805) re-
ported receiving telephone counseling and 34 % (271/
805) reported using NRT.
University of Alabama at Birmingham (UAB)
Treatment enactment was monitored using web-
system tracking of logins, the number of emails auto-
matically sent, and the number of emails sent to and
responded by the tobacco counselors as well as by pa-
tient recall of web participation from a subgroup of
participants (see Table 5). Of the 748 assigned to the
Table 1 Components of fidelity addressed by each study
Study design/Differentiation Training Delivery Receipt Enactment
UMMC Quasi-experimental design with 3
intervention hospitals and 2 usual
care hospitals decreased chances of
cross-over.
Packaged both nurse training and
patient intervention into a toolkit.
Pre- post-intervention nurse surveys





Increased chances of sustainability as
all nurses in intervention sites were
trained.
Research nurse trained trainers until
they demonstrated fidelity of
training.
Nurse interviews in intervention sites
only.
EMR download medications and
counseling.
Patient intervention manualized. Also see Fig. 1.
EMR download from nurse
documentation.
UCSD Randomization was completed using
iPads and tablets so recruiters had
timely access to randomized
condition, minimizing data entry
errors and cross-contamination of
intervention.
An operations manual guided
research staff on the various
components of the study.
Reports were generated from the
comprehensive UCSD database (that
combined both research-specific data
with intervention data) to ensure
protocol adherence (e.g., proper
number of attempts for counseling
clients, nicotine patches distributed to
clients, materials mailed, etc.).
Treatment receipt was assessed by
monitoring of quitline counseling
database, hospital documentation of
patch delivery, and self-report at
follow-up regarding receipt and use
of nicotine patches and/or quitline
services or other tobacco treatment.
Counseling adherence data
was collected from the
quitline documenting the
number of calls participants
completed.
Standardized training that included
role-play, was provided to recruitment
staff (i.e., respiratory therapists and
dedicated research recruiters) and
to quitline staff responsible for providing
the counseling intervention.
Also see Table 2. Two- and six-month evaluation
Calls contained self-reported
use of quitting aids (including
those from the study) and use
of behavioral treatment
(including quitline).
The project manager went into the
field quarterly, or when new
employees were hired, observed,
and provided feedback to staff to
ensure adherence to project
protocols.
The counseling used a structured
protocol.
Bi-weekly meetings allowed quitline
counselors to discuss specific
counseling cases and review skills,
increasing fidelity.
Timing, length, and frequency of
counseling calls was recorded.
KU Quitline Alere Well Being (AWB)
provided reports on how the patient
had been referred to the
quitline—fax or warm handoff.
A master’s degree level certified
tobacco treatment specialist trained
hospital tobacco use counselors.
Trainers observed counselors’
delivery of counseling and
counselor’s documentation of the
intervention.
Treatment receipt was assessed by
hospital treatment counselor
documentation and self-report at
follow-up as to whether participants
received quit line services or other
tobacco treatment.
Counseling adherence data
was collected from the
quitline documenting the
number of calls participants
completed.
Differentiation was assessed by
comparing records of group
assignment to the group file in
which AWB reported data back to
the research team.
Hospital counseling training included
didactics, role-playing, and supervised
delivery of the intervention.
Fidelity monitors observed a 10 %
convenience sample of the tobacco
use treatment sessions delivered in
the hospital.
During the training process, the
fidelity monitor observed new
A checklist was used to assess













Table 1 Components of fidelity addressed by each study (Continued)
trainee counselors at least once per
week.
treatment by intervention arm for
the study.
Hospital tobacco treatment
counselors used a counseling
checklist to document assessment,
smoking cessation medication usage
and recommendations, and referrals
to the quitline.
Also see Table 3.
Fidelity monitors assessed how well
counselors documented in the
medical record the treatment that
was provided.
NYU The processes of transferring
participant data to the Quitline
(control) and providing multi-session
telephone counseling (intervention)
were accomplished by different
study team members, limiting
chance of cross-over.
Standardized operating procedure
(SOP) manuals were developed for
all study procedures.
Intervention counselors completed
standardized documentation of their
counseling sessions using a study
database with close-ended and
open-ended fields to document the
number and duration of counseling
calls, correctness of contact
information, overall success in
reaching participants, NRT orders,
and topics covered.
Treatment receipt (i.e., patient
understanding of the intervention
and confidence) was not
systematically assessed.




Differentiation was assessed by
comparing participant group




20–30 h of initial training on the
counseling protocol.
Also see Table 4. 2-month follow-up surveys assessed
patient satisfaction with treatment.
Also see Table 4.
Training included didactic lectures,
role-plays and practice with standard-
ized patients
(actors trained to portray real patients).
Each month a random sample of
intervention counseling sessions
were audiotaped and reviewed by
the study’s clinical supervisor using a
standardized form assessing
adherence to the protocol and
counseling approach.
Intervention counselors participated
in weekly supervision with the
study’s clinical supervisor providing
an opportunity for training updates
(e.g., review of the protocol and
counseling approaches).
The study supervisor met with
counselors individually to review the
form and provide feedback.
UAB Treatment differentiation occurred by
limiting access of the web-site to those
randomized to the intervention
through registration to the website by
an intervention staff member.




The website tracked messages sent




number of days website
accessed, and number of
web pages visited.
The website tracked registrations,
log-ins and automated email messages
and subset of participants were
surveyed.













Table 1 Components of fidelity addressed by each study (Continued)
KPCHR Counselor documented assisted
referral acceptance, completion of
referrals to outpatient counseling,
and documented discharge
medication orders.
Study staff were trained and certified
in Good Clinical Practice.
Counselor completed a tobacco
consult checklist for
each smoker seen, and a study
enrollment checklist for
consented and randomized patients.
Counselor documented consult
topics discussed with the patient,
assisted referral acceptance and
referrals, and discharge medication
orders.
Utilization of quit resources




Counselor documented receipt of
printed quit information for patients
in the control group.
Counselors attended the same training
sessions on tobacco-dependence
treatment delivery for hospitalized
patients.
Counselors were monitored during
initial piloting, and participated in
ongoing case management discussions
among the counselor group.
IVR call attempts, call completions,
and responses, were monitored
electronically.
Documentation, including IVR
completion data, was tracked and
reviewed monthly by study staff.
Other staff received appropriate
training in use of the study’s
electronic data management system
at each site and in coding rules to
complete the forms properly.
Also see Table 6.
A participant screening and tracking
protocol was used to identify patients
with subsequent hospital admissions
to prevent reenrollment.
MGH Medication was provided exclusively
to intervention participants at the
time of hospital discharge (verified
by study ID).
For smoking cessation medication,
study staff were trained by the overall
coordinator and site coordinators to
obtain medication from the inpatient
pharmacy and deliver it to intervention
participants’ bedside at the time of
hospital discharge.
Medication – Study staff delivered
1 month of smoking cessation
medication to the patient’s bedside.
Study staff electronically
tracked medication
dispensation via a standard
database.
Similarly, only intervention
participants were entered into the
IVR database to receive calls after
hospital discharge (determined by
study ID).
Staff were also trained to enter
intervention participants’ information
into the IVR database so that they
could be called according to the
TelASK (participating IVR company)
protocol).
IVR calls were initiated by TelASK
with automated telephone calls to
smokers.
The study did not formally track
treatment receipt.
IVR calls were monitored by
TelASK and study staff via
secure access to a web-portal.
Telephonic behavioral
counseling enrollment and
calls were monitored by AWI
via standard database.
All call activity was recorded
electronically via call flow sheets, and
a subset of calls was randomly
selected by TelASK for internal
quality review.













Fig. 1 (UMMC): Self-Reported Treatment Delivery by Nurses Interviewed (n = 140)
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tered, 73 % at bedside and 25 % over the telephone.
Post-hospitalization calls by interventionists encour-
aging use of the website were completed for 64 % of
intervention participants, while another 34 % were left
detailed messages encouraging use. The web-system
documented at least 1 web-page was visited by 700
(94 %) participants with the mean number of pages
accessed being 5.4 (sd = 4.1; range 1–29). Ninety-one
participants (11 %) emailed the tobacco counselor two
or more times, while another 51 % emailed the
counselor at least once. When a subset of participants
(22 %; n = 167) were asked how often they read their
intervention emails, 27 % of respondents reportedTable 2 (UCSD): delivery of nicotine patches by condition (N = 637)
Total patch conditions (n = 637)
%
Received patches at discharge 62.8
Received patches by mail 35.5
Refused patches 1.7always, 19 % often, 24 % half the time, 13 % rarely, 5 %
never and 12 % did not respond. Participants were also
asked for comments regarding their experience with
the intervention, providing some insight into why the
website wasn’t used as much as planned (e.g., com-
puter problems, not comfortable with using a website,
found it confusing) and how the emails were perceived
(e.g., boring, interesting, helpful, incessant).
Kaiser Permanente Center for Health Research (KPCHR)
Treatment delivery was assessed using a treatment
form to record components of counselor-patient dis-
cussion of tobacco use variables and an enrollment





Table 3 (KU): hospital counselor treatment delivery as measured by checklist and direct observation (N = 108)
Warm handoff (N = 57 observations) % performed
appropriately
Let patient know survey is over and now you will be moving into the treatment portion of the intervention. 98
Describe warm hand-off process 79
Explain to patient you will now call the quit line then hand them the phone 100
Explain they will talk to two people: first registration and second they will be transferred to the quit coach 98
Explain the registration person will ask some questions that might seem redundant (like we have already asked) 79
Let them know you will check back in on them after the call 100
Perform call, using appropriate language 100
Leave room, notify patient’s nurse or floor staff patient is talking to quit line, discuss medications for withdrawal if
appropriate.
97
Fax Referral (N = 51 observations)
Let patient know survey is over and now you will be moving into the counseling/ treatment portion of the intervention 98
Conduct assessment of smoking history readiness to quit 96
Briefly touch on benefits and barriers to quitting as appropriate 100
Provide accurate medication information, use elicit, provide, elicit 94
Build plan to quit/stay quit using the booklet (as needed) 94
Ask if patient requests cessation medication script on discharge 98
Summarize key topics, goals, and next steps 94
Description of Fax Referral Process
Someone will call at the number you provided soon after discharge 96
Explain they will talk to registration first and answer questions before talking to a counselor 75
Avoid telling patient they don’t have to take all calls 98
Discuss plans to obtain medications post discharge: 1. Discuss patient interest in post discharge medications. 2. Tell them
we will request a prescription from medical staff if appropriate. 3. Discuss how to obtain medication
96
Follow up with medical staff about inpatient and discharge medications 90
Table 4 (NYU): treatment delivery and enactment intervention
arm from counselor documentation and patient surveys (N = 805)
% performed
appropriately
Medications from Counselor Documentation
Interested in receiving Nicotine Replacement
Therapy (NRT) NRT from the studya
32
NRT provided by the study 31
Received a NRT prescription at discharge 8
Calls from Counselor Documentation
Completed at least one call 52
Completed 7 calls 14
Set a Quit Date 10
Used NRT 27
Two-month Patient Survey
Used telephone counseling 48
Used NRT 34
aData only available on participants who spoke with an intervention counselor
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597 study participants who were randomized to the
AR + IVR group, nearly all participants received nico-
tine withdrawal counseling, discussed tobacco use
and quit history, were assessed for medication con-
traindications, discussed available quit services, and
were provided printed quit materials (Table 6). Pa-
tients randomized to the AR + IVR group were of-
fered a referral to centralized counseling services or
a faxed referral to the quitline. Overall, 57 % ac-
cepted AR, 43 % accepted discharge medications, and
28 % accepted both. In one hospital, patients were
less likely to accept the AR than another hospital,
but more likely to accept medications and both
counseling and medications (p < .001). Patients’ pri-
mary care providers were notified 76 % of the time,
with nearly all providers notified in one hospital and
less than half notified in another. About half of the
intervention recipients completed call 1, and comple-
tion rates fell for each subsequent call.
Table 5 (UAB): treatment receipt and enactment from
web-system (n = 748) and a sub-set of participant self-reports at
6 months post-intervention (n = 172)
Website loginsa % system reported n = 748 % participant
reported n = 172
Never 6 32
1–2 times 78 28
3–5 times 11 24









More than 10 99 43
Counselor messages
via web-site
% System reported messages




3 or more 5
aOne login was during registration
Table 6 (KPCHR): tobacco cessation treatment receipt among ITSAR
and enrollment checklist and IVR service provider reports (N = 597)




Tobacco use/quit history 98
Contraindications for meds 95
Risk factors for quitting 95
Discussed quit services 99
Provided quit materials 99
Assisted referral to outpatient care
HES/fax to quitline 57
D/C meds arranged 43
Both 28
Primary care physician notified of quit program
enrollment
76
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Treatment delivery and enactment were both moni-
tored by tracking acceptance and participation in
treatment components among 529 intervention partic-
ipants (see Table 7). In terms of treatment delivery,
all 529 participants received one month of free medi-
cation at the time of hospital discharge, although only
51 % requested the 2nd month of medication (1st re-
fill) and only 19 % requested the 3rd (2nd refill). All
were enrolled into the TelASK IVR database and were
called after hospital discharge and almost 9 out of 10
(88 %) accepted at least 1 IVR call. Success of transfer
from the IVR call to counseling was also monitored.
In the first two months of the study, 33 % of calls
were dropped, in part due to participants hanging up
prior to transfer completion. After adjustment that
included reduced wait time and a recorded message
to remain on the line, the IVR-to-counselor successful
transfer rate increased and held steady reflecting a
successful transfer in 83 % of patients requesting
transfer to AWI. In terms of treatment enactment,
about one-third of those who accepted at least one
TelASK IVR call enrolled in telephone counseling
through AWI, with 20 % completing all 5 outgoing
counselor calls.intervention group recipients (AR + IVR) obtained from consult
Kaiser Sunnyside Medical Center
N = 414

















Table 7 (MGH): treatment delivery (Medication, IVR Calls) and
treatment enactment (Enrollment in Behavioral Telephone
Counseling) among Helping HAND 2 trial participants (N = 529)
Components of enhanced care Percent
Pharmacotherapy




NRT Combination Therapy 74
Bupropion <1
Bupropion + NRT <1
Varenicline <1
Varenicline + NRT <1
Received 1st refill 51
Received 2nd refill 19
Interactive Voice Response (IVR)







Number of calls accepted among those who enrolled
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Study design and training
There was little reported cross-contamination among
the study arms. Quasi-experimental studies, such as
the UMMC study can prevent intervention drift as
they allow for greater separation of groups or treat-
ment differentiation. UCSD and KU had fidelity mea-
sures of the usual care arm, which can measure
treatment differentiation between arms. Training was
universally applied across all of the studies and can
be enhanced by developing manuals and/or toolkits
for providers and patients as was done in the UMMC
and NYU studies. Training enhances standardization
across intervention activities [2] and reduces the risk
of variation in strength and elements of intervention
provided. Training increases competence, self-efficacy,
and confidence [24, 25].Delivery/Receipt/ Enactment
Once training is complete, continued monitoring is
necessary. Four of the studies (UMMC, KU, and
NYU, KPCHR) used a checklist to monitor interven-
tionists, but the items varied widely. The KU checklist
(see Table 3) was largely based on specific compo-
nents of their unique intervention. The UMMC
checklist (see Appendix 1) was based on Joint Com-
mission (JC) standards for inpatient smoking cessa-
tion interventions [26] and this approach can directly
translate into quality assurance. The KPCHR checklist
(see Table 6) was designed to capture key elements of
the US Public Health Service [27] and JC standards for
smoking cessation. The NYU checklist (see Appendix 2)
was based largely on the relationship the counselor built
with the patient, which is important as differences in
warmth and ease, interactional style, and therapist em-
pathy and self- efficacy can represent serious threats to fi-
delity [4, 28].
Delivery of medications ranged from 31 to 100 %
across the studies, with higher levels coming from
those studies that gave away free medications (UCSD
and MGH) and lower levels coming from those stud-
ies that sought to obtain prescriptions for the patient
in real world systems (NYU). Delivery of counseling
was highest among those studies that used automated
systems (websites and IVR systems) such as UAB,
KPCHR, and MGH, but this did not automatically
translate into treatment receipt and enactment. In the
KU study, warm hand-off versus fax referral did in-
crease enrollment in the quitline. In the UAB study
most participants in the intervention arm accessed
the website, but only about one-quarter participated
in email communication.
Some studies measured treatment enactment in two
ways showing concurrence or discordance between the
two measures. In the NYU study, patient reports of par-
ticipating in phone calls were only slightly lower than
those reported by counselors. In the UAB study, the
website reported fewer logins than a subset of patients
self-reported, perhaps due to social desirability or recall
bias, as patients were surveyed 6 months after discharge.
Automated systems, such as the IVR, telephone, and
website systems used in the KU, UAB, KPCHR, and
MGH studies provide easily available fidelity data. Yet,
automated data may not identify qualitative issues iden-
tified in observations of and surveys/interviews with in-
terventionists and patients as done in the UMMC, KU,
NYU, KPCHR, and other similar studies [29]. Unlike
data from automated systems, qualitative data can pro-
vide rich information about barriers and facilitators to
implementation.
In summary, all sites monitored their intervention and
study fidelity, in particular how they differentiated
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who engaged in it, what was delivered and to whom/
how much, and to a lesser extent, intervention receipt
and enactment by participants. Using these 5-
categories as a guide, the studies all achieved moni-
toring of each aspect, to greater and lesser degrees as
fit their programs. These examples may help other re-
searchers in developing their own fidelity monitoring
plans by identifying similar structural components
and the methods for those components described
herein.Challenges of fidelity monitoring
Recording treatment sessions and then having two
observers rate fidelity is considered the gold standard
[10], but can be very time consuming and costly,
especially in dissemination trials [11]. Some might
argue that fidelity monitoring fundamentally changes
the intervention itself in that the fidelity assurance
process serves as a reminder that would otherwise
not exist. If the fidelity assessment must be viewed as
part of the intervention, the validity of the interven-
tion is challenged when it is conducted without fidel-
ity checks once the research has been concluded and
the intervention continues to be usual care.
Rigid application of treatment protocols may im-
pede treatment delivery. The therapists may feel
“locked in” or resistant to “cookbook” approach. Fi-
delity arguably does not allow the provider to tailor
the intervention to the patient’s needs. For example,
treatment fidelity may interfere with sound clinical
judgment when shorter sessions or cultural adapta-
tions to a treatment protocol are warranted. It may
be a challenge to implement rigid protocols for smok-
ing cessation in busy inpatient settings [3, 10, 30].
While modifying an intervention presents a chal-
lenge to fidelity measurement [11], a realistic and
sustainable intervention may need to allow for adap-
tation and modification. Some studies make adapt-
ability under certain circumstances a requirement
[30–32]. While some researchers question that adap-
tations retain efficacy/effectiveness [2, 8], fidelity
checks can be used to empower the stakeholders to
actively participate in the process of adaptation.
Finding the optimal balance between fidelity and
adaptation requires a treatment design that allows for
modifications and also calls for competence among
interventionists to make appropriate treatment deci-
sions [33].Conclusion
Despite the challenges of measuring fidelity, the
seven CHART studies used a variety of methods toenhance fidelity with the goal of ensuring the accur-
ate delivery of smoking interventions with consider-
ation for feasibility and sustainability. The examples
provided can be used to guide future studies. Some
of the strategies to address fidelity may be more
adaptable to certain types of trials and matching
monitoring methods to study design and program de-
liverables will facilitate appropriate fidelity tracking.
For example, direct observation may work best in
RCTs where there are few interventionists, whereas
direct observation is more difficult in large imple-
mentation trials that could instead use provider sur-
veys. Researchers may determine which of the studies
described is similar to their own and consider meas-
uring fidelity in similar ways. The strengths, limita-
tions, potential need for adaptation, and costs of
fidelity monitoring need to be taken into consider-
ation when designing and implementing clinical
trials.
Appendix 1
(UMMC): Fidelity Nurse Interview Guide
DURING HOSPITAL STAY:
Patient was asked about tobacco use.
Smoking status was documented.
For patients, who are current tobacco users OR quit
within the last 12 months:
PATIENT WAS OFFERED COUNSELING DUR-
ING HOSPITAL STAY.
Quit Smoking brochure was provided.
PATIENT RECIEVED COUNSELING.
Behavioral coments:
Advised the patient to set a quit date, ideally within
2 weeks
Advised the patient to remove all tobacco products
from home and at work.
Discussed potential challenges to quitting, staying off
tobacco, and planning ahead on how to deal with the
challenges.
Provided the patient with strong messages of support
and encouragement,
Stop Smoking videotape was provided.
Tobacco Tactics workbook was provided.
Information about FDA-approved cessation medi-
cation was provided.
AT DISCHARGE:
Patient was offered referral to outpatient
counseling.
Patient recieved referral to outpatient counseling.
Patient was offered prescription for FDA-approved
cessation medication.
Patient received prescription for FDA-approved
cessation medication.
Bolded items are Joint Commision standards.
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Date: Study ID#:
TTS:
Fidelity Rater: Length of session: minutes
Counseling Session:
1 = 1st call 2 = Counseling 3 = Post-Quit
DOMAINS N/A Did not do OK Did well
1. Treatment Alliance/Non-specific effects
Outlines program for patients, obtains buy-in and forms
working relationship.
Demonstrates warmth. (E.g., “I can understand how you
feel.”) Took a personal interest in pt.
Demonstrates credibility. “E.g., “Many patients have found
that distracting themselves by doing something pleasant can
help them deal with the urge to smoke.”
Minimizes non-relevant (e.g., non-smoking-related)
conversation. (E.g., “I hear what you’re saying (reflect/
summarize). Let’s shift and talk about your smoking.”
Comments:
2. Assessment
Obtained history of smoking
Environment: Assesses smoking at home and among
friends and family
Elicited pros and cons of smoking
Elicited personal psychological/habit/physical components of
addiction
Discussed motivation to quit and helped patient expand
on meaning of their reasons. “You mentioned health,
what would be different if you had better health?”
“What are some reasons that’s important for you?”
Discussed confidence in ability to quit
Comments:
3. Counseling Skills
Asks more open-ended questions. (E.g., “Let’s spend a few
minutes talking about your quit date. Can you tell me
about the plan for this day?”)
Encourages change talk from patient (e.g., less talking by
TTS and more listening). Rule of thumb: Patient should
talk 3 times as much as the counselor.
Asks one question at a time.
Corrects assumptions and uses Elicit-Provide-Elicit framework
(E.g., “May I tell you a little about the effects of smoking
on ——?” “Actually, that’s what many people think, can I tell
you more about that?”
Uses empathic listening statements to Affirm patient’s
experience (reflection: simple, complex as needed)
Uses summaries/transition statements when introducing a
new topic/idea. E.g., “I understand that you want to quit
because of your health and for your children. These are
very important reasons. Let’s switch to a different, but
related topic and discuss some reasons why you like
smoking.”
Table 8 (NYU): fidelity counseling audio review form (Continued)
Comments:
4. Cessation Planning
Elicited patient ideas and exchanges information about
quit plan, including correcting assumptions.
Discusses NRT – past use, type of use, corrected assumptions
Helped patient set behavioral goals and a quit date
Identified triggers for smoking (psychological/habit/physical)
and environmental (family, friends who smoke)
Helped patient identify strategies for coping with triggers
Asks patient to review upcoming plan for the week in their
own words/check in re understanding
Gives encouragement. (E.g., “I know you can do this, and
I’ll be here to help you.”)
Reviews number of remaining sessions
Problem-solving (follow up calls)
Examines slip or relapse situations
Discuss and normalize withdrawal symptoms
Develops patient self-image as a non-smoker
Comments:
5. Adaptivity
Tailors the content of counseling to patient needs (e.g.,
active/passive engagement style; information-seeking/
avoidant; psychologically distressed/non-distressed;
motivated/unmotivated.) E.g., Mental health/anxious
patients may have difficulties with problem-solving and
follow-through. These patients may need a more directive
approach. Patients who are information-seeking may have
lots of questions; TTS is able to answer these but can keep
the counseling on course. Meets the patient where he/she
is at.
Tailors the content of counseling according to the session
flow (e.g., fluidity, flexibility). If a patient has quit, and more
time is spent talking about NRT, then spend a little less
time on motivation building.
Comments:
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